XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Millions
Dec. 04, 2020
USD ($)
$ / shares
shares
Jan. 22, 2020
shares
Dec. 24, 2019
USD ($)
$ / shares
shares
May 07, 2019
USD ($)
$ / shares
shares
Sep. 30, 2021
vote
shares
Dec. 31, 2020
shares
May 03, 2019
closing
Subsidiary, Sale of Stock [Line Items]              
Common stock, shares outstanding (in shares)         87,047,832 67,432,712  
Common stock voting rights votes | vote         1    
Number of years for increase of authorized shares   10 years          
Total common shares reserved for future issuance (in shares)         91,616,000    
Number of closings | closing             2
Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares) 24,341,607     9,730,534      
Warrants callable (in shares) 18,256,204     9,730,534      
Sale of stock price (in usd per share) | $ / shares $ 0.7464     $ 1.205      
Consideration received | $ $ 19.4     $ 16.7      
Shares issued upon conversion (in shares) 10     10      
Warrants, term       5 years      
Warrant exercise price (in usd per share) | $ / shares       $ 1.08      
Milestone Closing              
Subsidiary, Sale of Stock [Line Items]              
Consideration received | $     $ 24.6        
Preferred Class A | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Warrants callable (in shares)       4,158,980      
Sale of stock price (in usd per share) | $ / shares       $ 10.80      
Nonvoting convertible preferred stock issued (in shares)       415,898      
Class A-2 Convertible Preferred Stock              
Subsidiary, Sale of Stock [Line Items]              
Reverse stock split ratio     10        
Class A-2 Convertible Preferred Stock | Milestone Closing              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares)     3,288,390        
Warrants callable (in shares)     32,883,900        
Consideration received | $     $ 26.0        
Warrants, term     5 years        
Warrant exercise price (in usd per share) | $ / shares     $ 0.666        
Class A-3 Convertible Preferred Stock | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Warrants callable (in shares) 2,047,276            
Sale of stock price (in usd per share) | $ / shares $ 6.22            
Nonvoting convertible preferred stock issued (in shares) 272,970            
Warrants, term 5 years            
Warrant exercise price (in usd per share) | $ / shares $ 0.7464            
Warrants | Preferred Class A | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock price (in usd per share) | $ / shares       $ 0.125      
Warrants | Class A-3 Convertible Preferred Stock | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock price (in usd per share) | $ / shares $ 0.125            
Certain Directors and Executive Officers | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares) 833,208     526,083      
Certain Directors and Executive Officers | Preferred Class A | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Warrants callable (in shares)       526,083      
Proceeds from issuance of right to purchase common shares | $       $ 0.6      
Certain Directors and Executive Officers | Class A-2 Convertible Preferred Stock | Milestone Closing              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares)     121,581        
Warrants callable (in shares)     1,215,810        
Consideration received | $     $ 1.0        
Certain Directors and Executive Officers | Class A-3 Convertible Preferred Stock | Private Placement              
Subsidiary, Sale of Stock [Line Items]              
Warrants callable (in shares) 624,906            
Proceeds from issuance of right to purchase common shares | $ $ 0.6            
2019 Plan              
Subsidiary, Sale of Stock [Line Items]              
Number of additional shares authorized (in shares)   4,166,860          
Number of additional shares authorized yearly increase   5.00%          
Common stock available for future grant (in shares)         853,111    
Total common shares reserved for future issuance (in shares)         10,172,886